Sentence: Preliminary data combining trastuzumab with the antiangiogenic antibody bevacizumab is encouraging ; this combination will be tested in both early stage and late stage disease .
Drug combination annotation:
[{'class': 'POS', 'spans': ['trastuzumab', 'bevacizumab'], 'is_context_needed': False}]